Research Overview: SILDENAFIL CITRATE (VIAGRA) – 50 TABS PDE5 INHIBITOR – VIAGRA IN TABLETS Astera Labs
Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor originally developed for cardiovascular research before becoming widely studied for erectile dysfunction mechanisms. This pharmaceutical compound selectively inhibits the PDE5 enzyme, which breaks down cyclic guanosine monophosphate (cGMP) in smooth muscle cells. By blocking this degradation pathway, sildenafil citrate maintains elevated cGMP levels, leading to smooth muscle relaxation and vasodilation in research models. Scientists at Stroid UK Shop recognise this compound’s importance in vascular biology studies and erectile function research.
Laboratory Applications
Researchers investigate sildenafil citrate across multiple domains of cardiovascular and urogenital physiology. Primary research applications include examining nitric oxide signalling pathways, investigating smooth muscle relaxation mechanisms, and studying blood flow regulation in various tissue models. The compound serves as a valuable tool for understanding cyclic nucleotide metabolism and exploring the role of PDE5 in cellular signalling cascades. Research teams also utilise sildenafil citrate to study endothelial function, pulmonary hypertension models, and the broader physiological effects of selective phosphodiesterase inhibition. Many investigators source complementary research compounds from our erectile function research category alongside other research chemicals including SARMs and peptides for comprehensive laboratory protocols.
Technical Specifications
| Chemical Name | Sildenafil Citrate |
|---|---|
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Tablet Count | 50 tablets |
| Manufacturer | Astera Labs |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
This sildenafil citrate formulation is manufactured by Astera Labs exclusively for in-vitro laboratory research and analytical testing purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols and proper disposal methods when conducting studies with this PDE5 inhibitor compound. All research must comply with applicable institutional guidelines and regulatory requirements for pharmaceutical research compounds.
